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Purpose: The present study examines the structure and covariance of endogenous variation in gene expression across the
recently expanded family of C57BL/6J (B) X DBA/2J (D) Recombinant Inbred (BXD RI) strains of mice. This work is
accompanied by a highly interactive database that can be used to generate and test specific hypotheses. For example, we
define the genetic network regulating growth associated protein 43 (Gap43) and phosphatase tensin homolog (Pten).
Methods: The Hamilton Eye Institute (HEI) Retina Database within GeneNetwork features the data analysis of 346
Illumina Sentrix BeadChip Arrays (mouse whole genome-6 version 2). Eighty strains of mice are presented, including 75
BXD  RI  strains,  the  parental  strains  (C57BL/6J  and  DBA/2J),  the  reciprocal  crosses,  and  the  BALB/cByJ  mice.
Independent biologic samples for at least two animals from each gender were obtained with a narrow age range (48 to
118 days). Total RNA was prepared followed by the production of biotinylated cRNAs, which were pipetted into the
Mouse WG-6V2 arrays. The data was globally normalized with rank invariant and stabilization (2z+8).
Results: The HEI Retina Database is located on the GeneNetwork website. The database was used to extract unique
transcriptome signatures for specific cell types in the retina (retinal pigment epithelial, amacrine, and retinal ganglion
cells). Two genes associated with axonal outgrowth (Gap43 and Pten) were used to display the power of this new retina
database. Bioinformatic tools located within GeneNetwork in conjunction with the HEI Retina Database were used to
identify the unique signature Quantitative Trait Loci (QTLs) for Gap43 and Pten on chromosomes 1, 2, 12, 15, 16, and
19. Gap43 and Pten possess networks that are similar to ganglion cell networks that may be associated with axonal growth
in the mouse retina. This network involves high correlations of transcription factors (SRY sex determining region Y-box
2 [Sox2], paired box gene 6 [Pax6], and neurogenic differentiation 1 [Neurod1]), and genes involved in DNA binding
(proliferating cell nuclear antigen [Pcna] and zinc finger, BED-type containing 4 [Zbed4]), as well as an inhibitor of DNA
binding (inhibitor of DNA binding 2, dominant negative helix–loop–helix protein [Id2]). Furthermore, we identified the
potential upstream modifiers on chromosome 2 (teashirt zinc finger homeobox 2 [Tshz2], RNA export 1 homolog
[Rae1] and basic helix–loop–helix domain contatining, class B4 [Bhlhb4]) on chromosome 15 (RAB, member of RAS
oncogene family-like 2a [Rabl2a], phosphomannomutase 1 [Pmm1], copine VIII [Cpne8], and fibulin 1 [Fbln1]).
Conclusions: The endogenous variation in mRNA levels among BXD RI strains can be used to explore and test expression
networks underlying variation in retina structure, function, and disease susceptibility. The Gap43 and Pten network
highlights the covariance of gene expression and forms a molecular network associated with axonal outgrowth in the adult
retina.
A key challenge in ophthalmology is defining genetic and
molecular mechanisms that underlie retinal disease. Recent
advances in genomics offer great opportunities to begin to
unravel  complex  genetic  networks  that  often  contribute
significantly  to  retinal  diseases  such  as  glaucoma  [1,2],
macular degeneration [3,4], and retinopathies [5-7]. Studies
in humans are of course the main drivers of this research
program, but it is often significant to have well defined genetic
models for detailed mechanistic and molecular analysis. One
novel and powerful approach that we have exploited combines
elements of systems biology and complex trait analysis by
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using a genetic reference panel that consists of more than 75
C57BL/6J (B) X DBA/2J (D) Recombinant Inbred (BXD RI)
strains of mice [8-14].
Collectively this large family provides a powerful system
to  integrate  baseline  phenotypes  of  nominally  wild-type
strains, a) with heritable risk of disease (for example, many of
the  BXD  strains  develop  a  severe  form  of  glaucoma)
[15-18]; b) with natural variation in expression and other
traits,  such  as  cell  population  sizes  [15,16,19];  c)  with
matched  studies  on  effects  of  interventions  on  disease
progression; and finally d) with the ability to identify some of
the causal gene variants segregating within this family that
contribute to ocular disease [12,13,20].
The second component—the systems biology approach
—takes advantage of high throughput expression profiling of
the  entire  family  of  strains.  The  expression  data  from  80
strains and both sexes would be overwhelming without special
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1355analytic tools, and for that reason we have integrated the entire
data set in GeneNetwork for rapid online analysis. In Figure
1, we illustrate the process of exploiting natural perturbations
of gene expression to define specific molecular networks in
retina. We provide one example that highlights a network
associated with axonal outgrowth in the adult mouse retina.
This network is defined in part by high natural covariance
among transcription factors: SRY (sex determining region Y)-
box  2  [Sox2]  and  paired  box  gene  6  [Pax6],  neurogenic
differentiation  1  [Neurod1]),  genes  involved  in  axonal
outgrowth  (growth  associated  protein  43  [Gap43]  and
phosphatase tensin homolog [Pten]), genes involved in DNA
binding (proliferating cell nuclear antigen [Pcna] and zinc
finger, BED-type containing 4 [Zbed4]), and an inhibitor of
DNA binding [inhibitor of DNA binding 2, dominant negative
helix–loop–helix protein [Id2]). The use of a systems genetics
approach that exploits large expression data sets for entire
families of strains with online resources provides a powerful
and practical way to study and test the genetics of retinal
function and disease susceptibility.
METHODS
Animals: Strains, sex, and age: Benjamin A. Taylor at The
Jackson Laboratory (Bar Harbor, Maine) generated the BXD
RI mouse strains 1 through 42; BXD RI 1 through BXD RI
32 strains were generated starting in the late 1970s [21] and
the BXD RI 33 through BXD RI 42 were bred in the 1990s
[22]. BXD RI strains 43 through 103 were generated in the
late 1990s and early 2000s using advanced intercross progeny
by  Lu  Lu,  Jeremy  Peirce,  Lee  M.  Silver,  and  Robert  W.
Williams [23]. Collectively, 80 strains of mice are represented
within the Hamilton Eye Institute (HEI) Retina Database,
including 75 BXD RI strains (n=307), C57BL/6J (n=4), DBA/
2J (n=4), the progeny of reciprocal F1 crosses of C57BL/6J
(n=4), and DBA/2J (n=4), as well as BALB/cByJ (n=4) mice.
All animals used within this study were purchased from The
Jackson  Laboratory  or  were  obtained  from  the  breeding
colonies of Drs. Robert Williams and Lu Lu at the University
of Tennessee Health Science Center (UTHSC, Memphis, TN).
Our goal was to collect data for independent biologic samples
from both male and female mice for all the available BXD RI
strains. All of the animals were young adults between 48 and
118 days of age (see Appendix 1). All mice were housed in
standard cages with water and chow available ad libitum. The
housing room was maintained on a reversed 12 h:12 h (6:00
AM–6:00 PM) light–dark cycle. All protocols used in this
study were approved by the Animal Care and Use Committee
of the UTHSC and were in accordance with the Institute for
Figure  1.  The  Hamilton  Eye  Institute
(HEI)  Retina  Database  and
GeneNetwork can reveal the covariance
in  gene  expression  that  establishes
genetic networks in the retina. A: Input:
A  systems  biology  approach  and  the
microarray data from 75 BXD RI mouse
retinas  feed  into  the  HEI  Retina
Database. B: Databases: The HEI Retina
Database  links  to  the  interactive
GeneNetwork  Database  website.  C:
Analysis:  The  analytical  tools  within
GeneNetwork are used to interrogate the
data  set  and  detect  the  co-variance
among  sets  of  genes  that  map  to  a
common genetic locus and collectively
control a complex trait. D: Outcomes:
Identify the unique genomic loci that co-
vary  with  the  trait  of  interest,  which
lends to the discovery of quantitative
trait  loci  (QTL),  cellular,  and  tissue
signatures. These signatures allow the
construction  of  schema  for  genetic
networks.
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Research in Vision and Ophthalmology (ARVO) Statement
for the Use of Animals in Ophthalmic and Vision Research.
Replication and samples within the database: Collectively,
our data represent sampling of males (n=162) and females
(n=164) from 80 mouse strains (total n=326), without within-
strain-by-sex  replication.  Our  goal  was  to  obtain  data  for
independent biologic samples including at least two animals
from each sex for all BXD RI mouse strains. We were able to
obtain four animals from a total of 64 strains of BXD RI mice,
two male (M) and two female (F), totaling 256 retina samples.
In 13 of the 80 BXD RI strains, we were able to obtain greater
than four samples per strain: BXD RI 1 (n=4 F, n=2 M), 32
(n=3 F, n=2 M), 38 (n=4 F, n=2 M), 40 (n=2 F, n=3 M), 42
(n=3 F, n=2 M), 49 (n=2 F, n=3 M), 60 (n=3 F, n=2 M), 62
(n=2 F, n=3 M), 68 (n=2 F, n=5 M), 70 (n=2 F, n=3 M), 73
(n=4 F, n=2 M), 83 (n=2 F, n=3 M), and 103 (n=4 F, n=3 M).
Strict  quality  control  (defined  below)  and  the  lack  of
availability resulted in 16 strains in which we were unable to
collect two samples for one or both genders: BXD RI 5 (n=4
F, n=0 M), 16 (n=1 F, n=2 M), 31 (n=2 F, n=1 M), 39 (n=2 F,
n=1 M), 44 (n=1 F, n=1 M), 45 (n=4 F, n=1 M), 51 (n=1 F,
n=2 M), 55 (n=1 F, n=2 M), 56 (n=1 F, n=3 M), 66 (n=1 F,
n=2 M), 71 (n=1 F, n=2 M), 80 (n=1 F, n=2 M), 81 (n=2 F,
n=1 M), 89 (n=1 F, n=3 M), 92 (n=1 M; species extinct), and
102 (n=2 F, n=1 M). For clarification regarding the BXD RI
24 strain, there are two strains of BXD RI 24: BXD RI 24A
and 24. BXD RI 24A was cryorecovered in 2004 from a stock
of embryos (1988; generation 80 [F80]), and this strain does
not  exhibit  retinal  degeneration  (The  Jackson  Laboratory
strain identification is BXD24/TyJ). The BXD RI 24 strain
acquired a spontaneous mutation in the centrosomal protein
290  (Cep290)  at  the  retinal  degeneration16  allele  (rd16),
which  resulted  in  retinal  degeneration  [24].  The  Jackson
Laboratory now denotes this strain as BXD24b/TyJ. We have
used BXD RI 24 to denote this strain in our database since this
is the terminology used throughout all of the BXD RI strain
set databases.
Tissue and sample processing: All animals were sacrificed by
rapid  cervical  dislocation,  and  the  retinas  were  removed
immediately. The retinas were harvested during the light cycle
within the time frame 10:30 AM to 4:00 PM. Two retinas per
mouse were immersed in RNALater (Applied Biosystems,
Foster City, CA) and stored (4 °C) in a single tube overnight.
The  next  day  the  retinas  were  transferred  to  the  freezer
(−20 °C) for at least 24 h and then placed in long-term storage
(−80 °C). Total RNA was prepared from the retinal tissue with
RNA-Stat-60  as  described  by  the  manufacturer  (Tel-Test,
Friendswood, TX). RNA-Stat-60 (Tel-Test) is composed of
phenol  and  guanidinium  thiocyanate  in  a  mono-phase
solution, which aids in the homogenization of the tissue. The
addition  of  chloroform  (Sigma  Aldrich,  St.  Louis,  MO)
creates  a  biphasic  solution  composed  of  an  aqueous  and
organic phase. The total RNA remains in the aqueous phase
while the DNA and protein are extracted into an organic inter-
phase. The total RNA is precipitated from the aqueous phase
with  isopropanol  (Sigma  Aldrich),  washed  with  ethanol
(Decon Laboratories, Inc., King of Prussia, PA) and the RNA
is resuspended in nuclease free water (Applied Biosystems,
Foster City, CA). The concentration of the RNA solution was
determined by measuring the absorbance at 260 nm and 280
nm with the NanoDrop 1000A spectrophotometer (NanoDrop
Technologies, Wilmington, DE). The quality and purity of
RNA was assessed using an Agilent Bioanalyzer 2100 system
(Santa Clara, CA; housed at UTHSC Molecular Research
Center, Memphis, TN) determining the relative quantities of
18S and 28S RNA as well as the RNA integrity number (RIN).
The RIN classifies the total RNA indicating the presence of
contamination and evidence of RNA degradation based upon
a numerical value of 1–10. The ideal standard for frozen tissue
is an RIN value greater than 7, but for our studies we chose a
value of 8 or greater.
Biotinylation  of  cRNA,  hybridization,  and  samples:  Total
RNA (150 ng) was processed with the Illumina TotalPrep
RNA  Amplification  Kit  (Applied  Biosystems)  to  produce
biotinylated complementary-RNAs (cRNAs). This procedure
included the reverse transcription of RNA to synthesize the
first  strand  complementary-DNA  (cDNA),  second  strand
cDNA synthesis, cDNA purification, in vitro transcription to
synthesize cRNA, cRNA amplification, and purification. The
concentration  of  the  cRNA  solution  was  determined  by
measuring  the  absorbance  at  260  nm/280  nm  using  the
NanoDrop  1000A  spectrophotometer.  The  biotinylated
cRNAs  (1.5  µg/sample)  were  hybridized  to  the  Illumina
Sentrix®  Mouse  Whole  Genome-6  version  2.0  arrays
(Illumina, San Diego, CA) for 19.5 h at 58 °C (Illumina, San
Diego, CA).
To  avoid  false  genetic  differences  that  lead  to  the
reduction in the number of false cis-acting effects and the
inflation of false trans-acting effects, samples from each strain
were always pipetted onto different slides. Additionally, the
samples were loaded at random locations within the chip and
no two samples from a single strain were processed in a single
chip.
Illumina mouse genome arrays, annotation, and statistical
analysis: The HEI Retina Database contains the data analysis
of 346 Illumina Sentrix® Mouse Whole Genome-6 version
2.0 arrays (Illumina, San Diego, CA). The Mouse Whole
Genome-6  version  2.0  BeadChips  contain  approximately
45,000 probes per array based on RefSeq Release 22 and are
supplemented  with  Mouse  Exonic  Evidence  Based
Oligonucleotide (MEEBO) and content from the Functional
Annotation of Mouse for the RIKEN full-length cDNA clone
(RIKEN) [25,26]. The Illumina bead array confocal scanner
and Illumina BeadStudio version 3.3.7 (Illumina) were used
to scan the BeadChips and monitor the hybridization signals.
The quality of the hybridization and overall processing of the
Molecular Vision 2011; 17:1355-1372 <http://www.molvis.org/molvis/v17/a153> © 2011 Molecular Vision
1357BeadChips were monitored by visual inspection of both the
internal quality control checklist and raw scanned data.
A  quality  control  analysis  was  performed  within  the
Illumina  BeadStudio  software  to  eliminate  the  systematic
variation of nonbiologic origin within the raw microarray data
using  a  normalization  algorithm.  A  summary  of  the
normalization  can  be  found  in  the  Illumina  User  Guide
Review (Genome Studio, Gene Expression Module version
1.0 User Guide). Rank invariant normalization within the
BeadStudio  software  was  used  to  calculate  the  data.  In
addition,  Minimum  Information  About  a  Microarray
Experiment  (MIAME)  standards  [27]  were  used  for  all
microarray  data.  Once  this  data  was  collected,  a  Pearson
correlation matrix was created between all the samples. The
data  was  globally  normalized  in  a  four  step  process:  1)
Compute  the  log  base  two  of  each  raw  signal  value.  2)
Calculate the mean and standard deviation of each mouse
WG-6 v2.0 array. 3) Normalize each array using Equation 2z
+8. The result is to produce arrays that have a mean of 8 and
a standard deviation of 2. 4) Compute the mean of the values
for the set of microarrays for each strain. Technical replicates
were averaged before computing the mean for independent
biologic samples. These data do not have a special correction
for batch effects. The values in expression range from 6.25 to
18.08. The lowest level of expression is 6.25 for Illumina
(ILMN)_2747167  (Rho  GTPase  activating  protein  11A
[Arhgap11a]). The highest level of expression is 18.08 for
ILMN_2516699 (ubiquitin B [Ubb]).
RESULTS
Genetic control of transcription in the mouse retina: The HEI
Retina Database presents the retinal transcriptome profiles of
75  BXD  RI  strains  in  a  highly  interactive  website,
GeneNetwork.  The  analytical  tools  within  GeneNetwork
allow for the a) systematic interrogation of the data set by
identifying genetic variability across the BXD RI strains, b)
constructing genetic networks controlling the development of
the mouse retina, and c) defining the genomic loci underlying
complex  traits  in  the  retina.  To  define  genetic  networks,
quantitative  trait  analysis  within  GeneNetwork  is  used  to
reveal  quantitative  trait  loci  (QTLs)  that  modulate  gene
expression levels. Within the HEI Retina Database, there are
a total of 11,141 probes with significant QTLs; 6,711 are
trans-acting QTLs, while 4,078 QTLs are defined as cis-acting
QTLs. The cis-acting QTLs are located at the same genomic
locus as the gene of interest, while the trans-acting QTLs have
genomic loci that modulate gene expression on a different
location in the genome (for a complete discussion of trans-
acting QTLs and cis-acting QTLs see [13]). The significant
QTLs have a likelihood ratio statistic (LRS) over 15 (defined
by GeneNetwork), which is the measurement of the linkage
between  the  differences  in  mRNA  expression  and  the
differences  in  a  particular  DNA  sequence.  One  way  to
visualize the total number of QTLs in the HEI Retina Database
is to plot a genome-wide graph of all the QTLs, as shown in
Figure 2. The graph displays the location of the best QTL for
each probe set plotted against the corresponding location of
the  gene.  The  plot  of  the  chromosomal  location  of  each
transcript with the corresponding position of the transcript’s
largest QTL reveals the structure of the interactions of the
transcripts within the BXD RI retina. The diagonal (red) band
in  Figure  2  represents  the  cis-acting  QTLs,  which  are
responsible for initiating the variations in gene expression.
Generally, the cis-acting QTLs tend to have high LRS scores
(>25). QTLs plotted away from this diagonal band represent
the trans-acting QTLs and are most likely modulated by a cis-
acting QTL at that genomic locus. On average, the LRS scores
of the trans-acting QTLs tend to be lower than those of cis-
acting QTLs. The co-regulated transcripts are represented as
the vertical bands within the trans-acting QTLs. Thus, the
retinal genome graph allows the visualization of the genetic
sources of variation in the transcript expression of the retina
at a global level.
Cellular  signature  within  the  HEI  Retina  Database:  The
cellular signature of the genes that are uniquely expressed
within specific retinal cell types can be identified within the
HEI Retina Database; however, this does not mean that within
a single cell type there is only one network. In fact, all cells
will have multiple genetic networks that regulate specific
cellular functions. A list of cell signature genes is presented
in Table 1. For each of the cell signature genes listed in Table
1, GeneNetwork can be used to create a list of genes whose
expression levels are highly correlated and form a unique
signature of the expression pattern(s) within the specific cell
type.  For  example,  Gap43  forms  a  retinal  ganglion  cell
signature, and within the top 100 correlates of Gap43 (see
Appendix 2) we find genes such as G protein-coupled receptor
85  (Gpr85),  Janus  kinase1  (Jak1),  heat  shock  protein  1
chaperonin 10 (Hspe1), neuron specific gene family member
(Nsg1),  translin  (Tsn),  beta  helix-loop-helix  domain
containing, class B5 (Bhlhb5), cytochrome c, somatic (Cycs),
and  beclin  1,  autophagy  related  (Becn1).  The  top  100
correlates of Gap43 are a highly correlated list of genes with
the 99th and 100th gene (male specific lethal-2 homolog1
[Msl2l1] and family with sequence similarity 108, member C
[Fam108c, RIKEN clone]) having a correlation of r=0.79. The
QTL heat map for Gap43 (Figure 3A) reveals a unique set of
genomic loci that regulate this list of genes while displaying
a unique signature pattern of the genomic loci that modulate
the genes expressed in retinal ganglion cells. The collection
of  genes  forming  these  dense  bands  are  termed  signature
QTLs  [13].  Signature  QTLs  are  genetic  networks  with  a
unique set of genomic loci that co-vary with the trait Gap43.
Each band represents a region of the genome that modulates
the  collections  of  genes  that  are  co-regulated  within  the
specific cell type.
Within the Gap43 network, signature QTLs are found on
chromosomes 1, 2, 7, 12, 15, 16, and 19, as indicated by the
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the signatures of other cell types within the retina, such as
retinal pigment epithelial cells (Rpe65) and amacrine cells
(Chat; Figure 3B,C). The Rpe65 QTL heat map illustrates
signature bands on chromosomes 1, 9, and 16 (Figure 3B),
while the Chat QTL heat map presents signature bands on
chromosomes 1, 5, 7, and 9 (Figure 3C). These cell-specific
QTL signatures reflect the upstream modulators for the genes
that are uniquely expressed within each specific retinal cell
type. Furthermore, the QTL signatures reflect the functionally
relevant genetic networks within the specific cell type.
Examples of functional networks within the mouse retina: Our
initial analysis displayed the Gap43 signature as a cohort of
transcripts co-regulated by the signature QTLs in the retinal
ganglion cells. Gap43 is of particular interest to our laboratory
because of the Gap43 association with growing axons and
abortive  regeneration  in  the  retina  [28,29].  When  we
examined the list of genes that correlate with the expression
pattern of Gap43 across the BXD RI strain set, Pten was
discovered to have a relatively high correlation of 0.63 and
has a similar expression pattern across the BXD RI strains.
The  high  correlation  is  interesting  because  both  genes,
Gap43 and Pten, are expressed in the retinal ganglion cells
and  Pten  has  been  reported  to  be  involved  in  axonal
regeneration [30,31]. We hypothesize that Pten may share
similar modulating QTLs to Gap43. Additionally, Gap43 and
Pten may participate within one molecular pathway in the
retinal ganglion cells. Similar with the Gap43 signature, the
Pten signature displays QTLs on chromosomes 1, 2, 12, 15,
16,  and  19  (Figure  4),  which  suggests  that  Gap43  is  co-
regulated with Pten within the same genetic network of the
retinal ganglion cells. This network shares a series of signature
QTLs that may modulate the response of the ganglion cells to
axonal injury: either abortive regeneration [32] or potentially
axonal regeneration [30,31]. With further investigation of this
network,  it  may  be  possible  to  define  genes  that  act  as
modulators of both Gap43 and Pten. For example, when the
top 2,000 correlates of Gap43 and Pten are compared (see
Appendix 3), 1,109 genes are found to be in common, which
indicates  that  Gap43  and  Pten  participate  within  a  single
genetic network.
Genes within the Gap43/Pten network: While analyzing the
genetic  networks  of  Pten  and  Gap43,  several  genes  were
discovered  to  have  high  correlations  (0.5–1.0)  with  both
Pten  and  Gap43.  Id2,  Sox2,  Pax6,  Zbed4,  Pcna,  and
Neurod1 were found in the top 800 correlates of both Pten and
Gap43. Collectively and individually, these genes are known
to be involved in both mouse and human retinal development.
When the top 100 correlates for Pax6, Sox2, Pten, Gap43, Id2,
Neurod1, Zbed4, and Pcna are mapped, the patterns are almost
identical with two bands on chromosome 1, two bands on
chromosome 2, one band on chromosome 12, one band on
chromosome 15, one band on chromosome 16, and one band
on  chromosome  19.  This  indicates  that  these  genes  share
common signature QTLs, suggesting that they are all part of
the same genetic signature network.
Figure  2.  A  genome-wide  graph
displaying  the  quantitative  trait  loci
(QTL) distribution across the Hamilton
Eye  Institute  (HEI)  Retina  Database.
Each  point  on  the  graph  represents  a
single probe set. The x-axis plots the
locations of the QTLs controlling the
transcript  expression.  Positions  are
measured  in  mega  bases  (Mb)  from
chromosome 1 to chromosome X (1–
2600  Mb).  The  y-axis  plots  the
chromosomal  location  of  each  of  the
transcripts.  The  significant  levels  of
individual QTLs are color-coded. The
low  genome  wide  p-value  or  high
likelihood  ratio  statistic  (LRS)  are
represented by red, the intermediate p-
value/LRS  values  are  green,  and  the
high  genome-wide  p-value/low  LRS
values  are  presented  in  blue.  The
diagonal  (red)  band  plots  the  large
number of highly significant cis-acting
QTLs and the vertical bands represent
major  trans-acting  QTLs  that  co-
regulate large numbers of downstream
transcripts.  These  data  were  plotted
from the HEI Retina Database with a
false discovery rate of 0.2.
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additional ways to view this group of genes that form the core
of the Gap43/Pten network. Using the tools available within
GeneNetwork, a network graph was computed for the Gap43/
Pten network. The eight genes form the core of the Gap43/
Pten network (light blue) are shown in Figure 5. All of these
genes possess expression levels that highly correlate across
the BXD RI strains (r=0.5–1.0). The correlations between
each of these genes are color coded in the network graph
illustrated in Figure 5 and presented in Table 2. We find that
the average range of correlation is between 0.54 and 0.95. The
lowest correlation is between Id2 and Zbed4, with a value of
0.54,  while  the  highest  correlation  (0.95)  exists  between
Sox2 and Pax6.
To identify the intersecting sets of traits that correlate
with  Pten,  Neurod1,  Sox2,  Pax6,  Id2,  Pcna,  Zbed4,  and
Gap43,  we  performed  a  correlation  comparison  using  the
Pearson-correlation  method  with  a  threshold  of  0.5.  A
correlation comparison aids in the determination of shared
genetic correlations among groups of traits by correlating
them with all the records from the HEI Retina Database. The
results indicated that 1,287 sets of traits intersect with Pax6,
Sox2,  Pten,  Gap43,  Neurod1,  Pcna,  Id2,  and  Zbed4.  By
increasing the threshold we can focus on a more concentrated
number of genes that are shared among the signature network.
When the threshold value is set to 0.7, 88 genes were found
to share genetic correlations among the Gap43/Pten network
within the retina (see Appendix 4). These genes are tightly
correlated forming a genetic network that may be involved
with axonal growth and abortive regeneration.
To  determine  whether  this  network  has  a  causal
relationship(s), a partial correlation was performed between
the genes of the Gap43/Pten network. A partial correlation is
a  correlation  between  two  variables  that  remain  after
controlling for one or more other variables [33]. With this
analysis networks can be interrogated by selecting a primary
gene, a target gene, and control genes. If there is a significant
difference, one can infer that the controlled variables have
little effect and may not influence the variables or may not be
a part of the model. It was determined that not all genes had
a high correlation, indicating that all of the genes do not
represent or share causal relationships. Two examples are as
follows: Zbed4 was chosen as the primary gene and Id2 was
selected as the control; the change in the Δ value for the target
Neurod1 was less than 0.05. When Sox2 was selected as the
control, Pten was selected as the primary gene and Pax6 was
listed as a target; the Δ value yielded 0.05. If the partial
correlation exhibits a significant change, then there is a causal
link between the variables and the change is dependent on the
controlled variable. Numerous significant changes or causal
relationships were found between the eight genes, with the
majority of the genes having causal correlations above 0.8.
Table 3 displays a few examples of the partial correlations that
are believed to be of functional significance; however, they
require further biologic testing.
Identifying candidate genes within the Gap43/Pten network:
The  HEI  Retina  Database  and  the  tools  available  on
GeneNetwork can aid in identifying potential candidate genes
that  are  upstream  modulators  of  a  trans-acting  QTL  or
signature  trans-acting  band.  In  order  for  a  gene  to  be
considered as an upstream modifier candidate of a genetic
network, it must meet several minimal requirements. The first
requirement is that the gene must be at the genomic location
of the trans-acting band. If the gene is not at that genomic
TABLE 1. GENETIC SIGNATURES DISPLAYED IN THE HAMILTON EYE INSTITUTE RETINA DATABASE
Cell signatures Signature genes
Retinal Ganglion Cells Chrna6, Nrn1, Gap43, Thy1
Amacrine Cells, Cholinergic Starburst Chat
Amacrine Cells, GABA-ergic Gad1, Gad2
Amacrine Cells, A17 Type Slc6a4
Amacrine Cells, AII Rod Type Dab1, Gria3
Amacrine Cells, Glycinergic Slc6a9
Bipolar Cells Vsx2, Grm2
OFF Cone Bipolar Cells Tacr3, Vsx1, Glrb
ON Cone Bipolar Cells Gja7
Rod Photoreceptors Rho
Müller Glial Cells Slc1a3, Col9a1, Fzd5, Gpm6a, Mgll, Trim2, Rax, Qrsl2
Retina Pigment Epithelium Rpe65, Rdh5, Rgr, Ttr
Astrocytes Gfap
Vasculature System Edg3, Efnb2, Nr2f2, Pecam1, Vcam1
Circadian Rhythm Arntl, Clock, Per1
        Eleven different retinal cell type signatures including retinal ganglion cells, amacrine cells (5 types), bipolar cells (3 types), rod
        photoreceptors, muller glial cells, retina pigment epithelium, astrocytes, cell types involved in the vasculature system, and cells
        types involved in circadian rhythm are denoted in the left column and the genes associated with each cellular signature are
        displayed in the right column.
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1360locus, then the gene could not be considered a candidate.
Second, the expression of the gene should be highly variable
across the BXD RI strain set. The variability allows the gene
to be mapped and differentially influence gene expression.
The third requirement is that the gene must have a significant
LRS  score  (>17).  An  LRS  score  greater  than  17  has  a
significant linkage (p value ≤0.05) and indicates that the gene
can  affect  the  phenotypic  transcript  expression.  The
expression level should be above the mean expression level
of all the transcripts on the microarray (in GeneNetwork this
is a value of 8 or higher). Additionally, there should be a high
correlation  (>0.5)  between  the  gene  and  the  network,
indicating the theoretical/biologic relevance. Finally, an ideal
candidate would have a literature connection between the
candidate genes and the network. All of these criteria can be
monitored using the tools and links within GeneNetwork (for
a description of the use of these tools see [25]). For the purpose
of  illustration,  we  identified  the  candidate  genes  for  the
chromosome 2 and chromosome 15 trans-acting bands in the
Gap43/Pten network.
Candidate genes on chromosome 2: To identify the candidate
genes that modulate the Gap43/Pten network, a search was
Figure 3. The cellular signatures of growth associated protein 43 (Gap43), retinal pigment epithelium-specific protein 65 kDa (Rpe65), and
choline O-acetyltransferase (Chat) illustrated by quantitative trait loci (QTL) heat maps. The correlation matrices within GeneNetwork were
used to simultaneous map and analyze the top 80 genes in the trait collections of A: Gap43, B: Rpe65, and C: Chat. The gene collections from
Gap43, Rpe65, and Chat form unique signatures within the retina transcriptome. The numbers to the left denote the correlation range and at
the bottom of the heat maps the chromosomal location is noted ranging from chromosome 1 on the left to chromosome X on the right. The
banding pattern is displayed in yellow, red, green, and blue, which denote the locations of the genomic loci that modulate all of the genes in
the network. The hues: yellow, red, green, and blue represent significant QTLs. The green (low LRS) to blue (high LRS) coloring represents
transcripts whose expression is higher in the strains with a B haplotype (C57BL/6J) and the yellow (low LRS) to red (high LRS) coloring
corresponds to the transcripts whose expression is higher in the strains with mutant D haplotype (DBA/2J). The red arrows indicate that some
of the bands are more prominent. Running a QTL cluster map in GeneNetwork reveals a strong QTL signature of Gap43, forming a potential
genetic network. Signature QTLs (highlighted with red arrows) for Gap43 were found on chromosomes 1, 2, 7, 12, 15, 16, and 19. These are
regions of the genome that contain loci modulating the expression of genes within the Gap43 network (A). Rpe65 forms signature QTLs on
chromosomes 1, 9, and 16 (B) and Chat forms signature QTLs on chromosomes 1, 5, 7, and 9 (C).
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1361performed for all genes with cis-acting QTLs having an LRS
between 15 and 2,000, using a 20-Mb exclusion buffer, and a
mean between 7.5 and 60 on chromosome 2 between 169 Mb
and  182  Mb  (distal  band  on  chromosome  2).  Within  this
region of the genome, GeneNetwork returns 18 records in
which 16 genes are represented by 18 probes on the Illumina
microarray (Table 4). The 13-Mb region on chromosome 2
contains 36 genomic markers with an average of less than 0.5
Mb between each marker, creating an accurate genomic map.
When we examine the 16 genes present in this region, there
are genomic markers separating each of the candidate genes,
which rules out the possibility of linkage disequilibrium by
genomic  mapping.  To  narrow  the  candidate  genes,  we
eliminated the four RIKEN clones, removed duplicate probe
sets for teashirt zinc finger homeobox 2 (Tshz2), and deleted
the  genes  that  had  a  LRS<17  (RP23–330D3.5  and  ADP-
ridbosylation factor related protein 1 [Arfrp1]). Additionally,
the genes that have an expression value less than 8 were also
subtracted from the list (docking protein5 [Dok5], cadherin 4
[Cdh4], and potassium voltage-gated channel, subfamily Q,
member 2 [Kcnq2]). The remaining seven candidate genes
defined by this approach in the chromosome 2 trans-acting
band  are:  Tshz2,  RNA  export  1  homolog  (Rae1),  opioid
growth factor receptor (Ogfr), basic helix-loop-helix domain
containing,  class  B4  (Bhlhb4),  regulator  of  telomere
elongation  helicase1  (Rtel1),  heat  shock  protein  40  kDa
(Hsp40  or  DnaJ)  homolog,  subfamily  C,  member  5
(Dnajc5),  and  transcription  elongation  factor  A  (SII),  2
(Tcea2).
Candidate genes on chromosome 15: A similar analysis was
conducted to determine the candidate genes within the trans-
acting signature band found on chromosome 15. Using the
advanced search features in GeneNetwork, we performed a
search of the cis QTLs that have an LRS between 15 and 2,000,
using a 20-Mb exclusion buffer, a mean between 7.5 and 60,
and with target genes on chromosome 15 between 82 and 92
Mb. Within the 10-Mb region of chromosome 15, there are 42
genomic markers, which provide a high mapping density. The
search returns 20 records displaying 16 genes (Table 5). To
narrow our search, the RIKEN clone and the duplicate probe
sets  for  phosphomannomutase  1  (Pmm1),  X-ray  repair
complementing defective repair in Chinese hamster cells6
(Xrcc6), malonyl CoA-acyl carrier protein acyltransferase,
mitochondria (Mcat), and RAB, member of RAS oncogene
family-like 2A (Rabl2a) were removed from the list in Table
5. Serine hydrolase-like (Serh1) and fibulin1 (Fbln1) can be
Figure 4. Quantitative trait loci (QTL) Heat Map of the top 100 correlates of phosphatase tensin homolog (Pten). The numbers to the left
denote the top 100 genes that correlate with Pten and the chromosomal location is noted at the bottom of the heat map ranging from chromosome
1 on the left to chromosome X on the right. The banding pattern is displayed in yellow, red, green, and blue, which denote the locations of
the genomic loci that modulate all of the genes in the network. The green (low likelihood ratio statistic; LRS) to blue (high LRS) coloring
represents transcripts whose expression is higher in the strains with a B haplotype (C57BL/6J) and the yellow (low LRS) to red (high LRS)
coloring corresponds to the transcripts whose expression is higher in the strains with mutant D haplotype (DBA/2J). The red arrows indicate
the most prominent bands with significant QTLs and portray the signature bands of the Pten network chromosomes 1, 2, 12, 15, 16, and 19.
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1362deleted from the selected genes because they do not display a
mean expression value of 8.0 and aconitase 2, mitochondrial
(Aco2). can be eliminated from the list due to the LRS being
below  17.  Zbed4,  one  of  the  genes  displayed  within  the
Gap43/Pten network, has a cis-QTL on chromosome 15 at
87.3 Mb and its expression is highly correlated with the other
genes in the Gap43/Pten network, as shown in Figure 5. As a
result,  this  suggests  that  Zbed4  would  make  an  excellent
candidate gene for the Gap43/Pten network; however, we
have left Zbed4 out of our candidate gene analysis because the
Zbed4 analysis was previously performed with the Gap43/
Pten network. Thus, it was established that 11 genes met the
search criteria: PHD finger protein5A (Phf5a), polymerase
(RNA)  III  (DNA  directed)  polypeptide  H  (Polr3h),
phosphomannomutase  1  (Pmm1),  X-ray  repair
complementing defective repair in Chinese hamster cells6
Figure 5. A network graph representing
the  growth  associated  protein43/
phosphatase  tensin  homolog  (Gap43/
Pten)  network  and  the  potential
components for upstream modulation of
the Gap43/Pten network. This network
graph  produces  a  relational  Gap43/
Pten  network  shown  in  blue.  The
colored  lines  represent  the  direct
correlative relationship and the strength
of the correlation is −1.0 to 1.0. The
genes denoted in red: Basic helix loop
helix beta4 (Bhlhb4), teashirt zinc finger
homeobox 2 (Tshz2), and RNA export
protein1 homolog (Rae1) are candidates
from chromosome 2, cis-acting QTLs
between 169 Mb and 182 Mb. The genes
illustrated  in  green  are  the  candidate
genes  located  on  chromosome  15
between  82  Mb  and  92  Mb;
phosphomannomutase1  (Pmm1),
copine VIII (Cpne8), RAB, member of
RAS  oncogene  family-like  2A
(Rabl2a), and fibulin 1 (Fbln1).
TABLE 2. CORRELATION MATRIX THAT DISPLAYS THE HIGHLY CORRELATIVE EXPRESSION LEVELS OF SOX2, PTEN, GAP43, ID2, NEUROD1,
ZBED4, AND PCNA.
Gene symbol Neurod1 Pax6 Pcna Sox2 Id2 Gap43 Pten Zbed4
Neurod1 1 0.85 0.84 0.81 0.63 0.75 0.7 0.93
Pax6   1 0.88 0.95 0.73 0.68 0.63 0.84
Pcna     1 0.86 0.71 0.63 0.74 0.78
Sox2       1 0.76 0.68 0.65 0.8
Id2         1 0.64 0.67 0.54
Gap43           1 0.58 0.7
Pten             1 0.64
Zbed4               1
        Correlation matrix that displays the highly correlative expression levels of the growth associated protein43/ phosphatase tensin
        homolog (Gap43/Pten) network including: beta loop helix beta transcription factors (sex determining region Y-box 2 [Sox2]
        and paired box gene 6 [Pax6]), a neuron specific transcription factor for neuronal development (neurogenic differentiation 1
        [Neurod1]), genes involved in DNA binding (proliferating cell nuclear antigen [Pcna] and zinc finger, BED-type containing 4
        [Zbed4]), and an inhibitor of DNA binding (inhibitor of DNA binding 2, dominant negative helix–loop–helix protein [Id2]).
        The gene symbols are located in the first column, and the first row of the table illustrates the corresponding levels of correlative
        expression (0.54–1.0).
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1363(Xrcc6), malonyl CoA-acyl carrier protein acyltransferase,
mitochondria  (Mcat),  PHD  finger  protein  21B  (Phf21b),
TBC1 domain family, member 22a (Tbc1d22a), arylsulfatase
A (Arsa), RAB, member of RAS oncogen gamily-like 2A
(Rabl2a), copine VIII (Cpne8), and kinesin family member
21A  (Kif21a).  Additionally,  there  were  two  genes,
peroxisome  proliferator-activated  receptor  (Ppara)  and
fibulin 1 (Fbln1), which appeared to be good candidate genes;
however, these genes did not meet the criteria initially used in
the search. Ppara has a strong cis-acting QTL with an LRS
score of 59.7; however, the expression level of Ppara is two-
fold below the mean expression on the microarrays. Even
though Ppara has a lower expression level than our initial
criteria, it was included in the candidate gene list due to its
strong cis-acting QTL. Fbln1 was included in the candidate
gene  list  for  similar  reasons;  it  has  as  strong  cis-QTL
(LRS=24) and was just below (7.6) the expression cut-off
criterion of 8.0.
Using  network  correlation  to  prioritize  candidate  genes:
Additional criteria can be used to narrow the list of candidate
genes. Our initial analysis of the chromosome 2 locus revealed
seven potential genes are upstream modulator candidates of
the Gap43/Pten network and chromosome 15 has thirteen
potential  candidate  genes.  With  such  a  large  number  of
candidate genes (20 total candidate genes), it is difficult to
begin to plan any biologic experiments to validate which gene
is modulating the network. One approach is to identify genes
that show similar expression(s) patterns as the other genes
within the network that they are potentially modulating. Thus,
the candidate genes were prioritized based upon the genes that
are most likely to have a direct effect on the Gap43/Pten
network. Within the GeneNetwork, the candidate genes for
the  Gap43/Pten  network  from  chromosome  2  and
chromosome 15 (Table 4 and Table 5) are added to a collection
with the core of the Gap43/Pten network (Gap43, Pten, Pcna,
Id2,  Neurod1,  Zbed4,  Pax6,  and  Sox2).  The  network
correlation  program  was  processed,  we  selected  only  the
candidate genes with a high correlation (0.5), and the most
direct  connection  to  the  network  genes  (Figure  5).  These
criteria narrowed our search to seven genes (Tshz2, Rae1,
Bhlhb4, Rabl2a, Pmm1, Cpne8, and Fbln1) that could be
considered as potential candidates for modulating the Gap43/
Pten network.
Within the distal signature band on chromosome 2, it was
determined that Tshz2, Rae1, and Bhlhb4 are located within
the  top  2,000  correlates  for  Pten.  This  correlation  in  the
expression pattern across the BXD RI strain set is a strong
indicator  that  these  genes  are  potential  candidates  for  an
upstream modulator of the trans-acting band on chromosome
2. Rae1 has a negative correlation with Id2 (−0.53) and Pten
(−0.54).  Bhlhb4  positively  correlates  with  Pcna  (0.53),
Neurod1 (0.5), Sox2 (0.55), Id2 (0.54), Pten (0.68), Pax6
(0.5), and Gap43 (0.56). Tshz2 correlates with Bhlhb4 (0.54),
Gap43 (0.52), Id2 (0.53), Pax6 (0.54), Pcna (0.55), Sox2
(0.66), Pten (0.54), and Zbed4 (0.51). Thus, it appears that on
the chromosome 2 locus there are three potential candidate
genes: Rae1 (a potential negative modulator of the network),
Bhlhb4 (a putative positive modulator of the network), and
Tshz2 (putative positive modulator of the network).
The  potential  candidates  for  chromosome  15  were
Rabl2a, Pmm1, Cpne8, and Fbln1. Pmm1 is the only candidate
gene located in the top 2,000 correlates of Pten; however,
Cpne8,  Pmm1,  and  Rabl2a  were  found  in  the  top  2,000
correlates of Gap43. Through this analysis, both potential
positive and negative modulators of the network were found
as indicated below. Rabl2a has a negative correlation value of
0.5–0.7  with  Pax6  (−0.57),  Id2  (−0.62),  Fbln1  (−0.52),
Gap43 (−0.61), Cpne8 (−0.68), and Zbed4 (−0.51). Pmm1
also  has  a  negative  correlation  with  several  genes  in  the
network, such as Pax6 (−0.68), Pcna (−0.7), Sox2 (−0.72),
TABLE 3. A SAMPLE TABLE FROM A PARTIAL CORRELATION TABLE DISPLAYING EXAMPLES OF GENES THAT HAVE CAUSAL RELATIONSHIPS BY
SELECTING A PRIMARY TRAIT, CONTROL TRAIT, AND A TARGET TRAIT.
Primary Control Target Delta value
Pax6 Sox2/Pten Id2 0.8
Pax6 Pcna/Zbed4 Neurod1 0.94
Sox2 Pcna/Zbed4 Neurod1 0.97
Sox2 Pax6/Pten Neurod1 0.98
Sox2 Pax6/Pten Zbed4 0.92
Zbed4 Pax6 Sox2 0.87
Neurod1 Pax6 Sox2 0.82
Id2 Sox2/Gap43 Pax6 0.86
         A sample of the partial correlation table displaying examples of the genes that have causal relationships within the growth
         associated protein 43/phosphatase tensin homolog (Gap43/Pten) network. Significant changes or causal relationships were
         identified between the genes in the Gap43/Pten network. The genes defined as having causal correlations display a value of 0.8
         or above. The columns represent the selection of a primary trait (gene), control trait (gene), target trait (gene), and the significant
         change or delta value observed.
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1366Zbed4  (−0.57),  Neurod1  (−0.56),  Gap43  (−0.59),  Cpne8
(−0.57), Id2 (−0.62), and Fbln1 (−0.57). Cpne8 displays a
positive  correlation  with  Pax6  (0.71),  Pcna  (0.64),  Sox2
(0.77), Zbed4 (0.62), Id2 (0.63), Fbln1 (0.57), Gap43 (0.65),
Pten (0.5), and Neurod1 (0.63); however, Cpne8 negatively
correlates with Rabl2a (−0.65) and Pmm1 (−0.62). Fbln1 has
positive correlations with Pax6 (0.6), Sox2 (0.64), Id2 (0.68),
Cpne8 (0.62), and Gap43 (0.51); however, Fbln1 also has
negative correlations with Pmm1 (−0.56) and Rabl2a (−0.
59).
Another  approach  to  minimize  and  prioritize  the
candidate genes is to perform a literature search. Although
sparse, we unveiled literature correlations for at least four of
the candidate genes. Bhlhb4 is a transcription factor that is
required for the rod bipolar cell maturation [34]. It is well-
known that the bipolar cells receive input from the cones and
many feed into the retinal ganglion cells [35]. PMM1 has been
associated  with  a  degenerative  disorder,  CDG1
(carbohydrate-deficient glycoprotein deficient syndrome type
I), which can present ocular degeneration symptoms [36-38].
FBLN1 was recently discovered as a downstream target of SP1
transcription  factor  (SP1)  in  a  manuscript  regarding  the
network  analysis  of  human  glaucoma  [39].  RABl2A  is
ubiquitously  expressed  in  humans  [40]  and  has  been
associated with F379, which is a retina-specific transcript
[41]. Thus, the literature search implicates that four of the
seven candidate genes, Bhlhb4, Fbln1, Rabl2a, and Pmm1,
would be valid components of Gap43/Pten network.
DISCUSSION
There  is  a  tremendous  need  to  develop  interactive  tissue
databases  to  organize,  sort,  and  mine  the  vast  amount  of
genomic data. This is especially true if we are to define the
genetic basis of complex traits and diseases. Over the years
many  approaches  and  technologies  have  been  created  to
identify  genes  that  are  expressed  in  the  retina,  such  as
expressed  sequence  tag  information  [6,42-47],  sequencing
cDNA  libraries  generated  by  conventional  methods  or
normalization  techniques  [48-55],  hybridization  to  gene
arrays of various formats [56,57], and serial analysis of gene
expression [46,47,58,59].
Many of these approaches are now available as databases,
and  we  have  summarized  them  in  Table  6.  In  2009,  the
National Eye Institute held a workshop to help identify the
gaps, needs, and opportunities in ophthalmic genetics. This
included ophthalmic disease conditions, biologic systems, and
approach/methodologies. A few concerns were identifying
the major genes and the modifiable risk factors that cause
glaucoma,  identification  of  the  modifier  genes  for  retinal
degeneration, appropriate animal models to study complex
disease,  and  approaches  for  statistical  genetics.  The  HEI
Retina Database, which combines 75 BXD RI strain sets with
systems biology, is a unique and powerful approach that will
help to address some of these questions. The HEI Retina
Database is an interactive website within GeneNetwork that
provides  a  transcriptome-wide  analysis  of  the  retina,  thus
enabling the study of genetic networks present within the
retina.
The HEI Retina Database provides a powerful model to
study the genetic covariance of the 75 BXD RI strains because
it allows researchers to identify cellular signatures and genetic
networks within the retina. Both the Hamilton Eye Institute
Mouse  Expression  Database  (HEIMED)  and  HEI  Retina
Database  in  conjunction  with  GeneNetwork  enhance  the
power of the bioinformatic resources listed in Table 6 by
providing unique sets of bioinformatic research tools. The
HEI  Retina  Database  characterizes  the  genetic  networks
regulating the complex structure of the retina, identifies the
variation in retina phenotypes and disease susceptibility, and
determines the gene variants that have expression patterns
closely associated with higher order phenotypes. Thus, the
HEI  Retina  Database  provides  a  wealth  of  research
possibilities, including: a) defining the molecular signatures
within the retina, b) ascertaining the unique cell signatures for
a specific cell type, c) identifying candidate genes for human
disease, d) ability to understand genetic networks regulating
tissue-specific  gene  expression,  and  e)  determining  the
TABLE 6. SUMMARY OF RETINA DATABASES CURRENTLY AVAILABLE.
Databases Contents
National Eye Institute: NEI Bank Project Transcriptome profiling for different tissues of the eye for a variety of different species including mouse
and human
Mouse Retina Serial Analysis of Gene Expression
(SAGE)
Gene expression data from the embryonic and postnatal mouse retina.
Scripps Friedlander Gene Expression Expression of retinal transcripts for the mouse retina during eight different postnatal stages.
Retinal Information Network Mapped loci and cloned genes associated with inherited retinal disease.
Retinal International Website Series of databases listing: retinal diseases, mutations affecting the eye, current animal models, and
known proteins involved in retinal disease.
GENSTAT: Retina Project Cell specific labeling in the retina using BAC transgenic mice.
Retina Central Integrated platform for gene related information regarding the adult mammalian retina
        The summary table includes the database names, followed by a brief summary of the contents of the database, and the website
        address associated with the retina databases.
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1367complex interactions of the genomic loci that underlie the
complex structures of the retina. This approach may lead to
additional  studies  further  evaluating  system  genetics  and
complex trait analysis using the links within GeneNetwork
such  as  UCSC  Genome  Browsers,  Ensembl  Genome
Browser,  PubMed,  Entrez  Gene,  ABI  panther,  and
WebGestalt.
One example of the discovery of genetic networks within
the HEI Retina Database/GeneNetwork is the Gap43/Pten
network. This example provides a unique genetic signature
for retinal ganglion cells. The QTL heat map for Gap43 led
us to a unique cellular signature that is similar to Pten, which
suggests that the two genes may participate in one molecular
pathway in retinal ganglion cells. Additionally, the similarity
suggests that Gap43 co-regulates Pten with a collection of
genes (Pax6, Sox2, Id2, Neurod1, Zbed4, and Pcna) that are
strongly associated with this network. These genes possess the
same genetic signature network as indicated by the common
signature QTLs on chromosome 1, 2, 15, 16, and 19 as well
as  displaying  high  correlations  between  the  genes  (>0.5).
Additional interrogation of the Gap43/Pten network indicated
a causal link between some of the genes, as displayed in Table
2. GeneNetwork pinpointed the potential upstream modifier
candidates for the Gap43/Pten network with implementation
of stringent criteria (as discussed within the results section):
a) the genomic location of the trans-acting band and gene of
interest must co-exist, b) high variability in expression levels
across the strain set, c) significant LRS scores (>17), d) mean
expression above 8, e) high correlations between the gene of
interest  and  the  network  (>0.5),  as  well  as  f)  a  literature
correlation between the network and gene of interest. Using
these  criteria,  seven  candidates  from  chromosome  2  and
thirteen candidates from chromosome 15 were selected as
potential  upstream  modifiers  of  the  Gap43/Pten  network.
Based  upon  the  similar  expression  patterns,  strong
correlations (>0.5) in the expression patterns across the BXD
RI  upstream  modulators,  and  a  direct  connection  to  the
network genes (Pax6, Sox2, Id2, Neurod1, Zbed4, and Pcna),
the search for candidates was narrowed to seven genes of
interest (Tshz2, Rae1, Bhlhb4, Rabl2a, Pmm1, Cpen8, and
Fbln1), as shown in Figure 5.
Throughout the literature, several studies have attempted
to  determine  retinal  signature  genes  and  networks.  Three
recent  publications  indicate  a  direct  link  to  our  systems
biology approach and the study of genetic networks in the
retina [60-64]. Publications by Ivanov and colleagues [60]
were of particular interest to our laboratory because they are
identifying the retinal ganglion cell enriched genes that are
preferentially expressed in the adult retinal ganglion cells. At
least five candidate genes from the study of differential gene
expression profiling of retinal ganglion cells [60] share similar
QTL  heat  maps  to  the  Gap43/Pten  network:  mitogen-
activated protein kinase 1 (Map2k1), coagulation factor C
homolog,  cochlin  (Coch),  tyrosine  3-monooxygenase/
tryptophan  5-monooxygenase  activation  protein,  beta
polypeptide (Ywhab), tyrosine 3-monooxygenase/tryptophan
5-monooxygenase  activation  protein,  zeta  polypeptide
(Ywhaz), and plastin 3 (Pls3). The similarity between the QTL
heat maps as well as the molecular functions of these genes
(Map2k1, Coch, Ywhab, Ywhaz, and Pls3) suggests that they
are likely to participate in the Gap43/Pten signature network
[60-63]. Recent studies of the expression changes in retinal
ganglion  cells  further  indicate  that  Ywhab  and  Ywhaz
[60-63] are strong candidates for the Gap43/Pten network.
Ywhab and Ywhaz are of interest because their chromosomal
location  is  associated  with  the  Gap43/Pten  network,
chromosome 2 and chromosome 15, respectively, and they
share 99% homology in the mouse and rat. Both Ywab and
Ywhaz have been linked to the mitogenic signaling and cell-
cycle machinery within the retina, as demonstrated by the
genes in which they associate and interact. Ywhaz’s encoded
protein  is  known  to  interact  with  CDC25B  [65],  C-RAF
[66-70],  AKT1  [71],  P53  [72],  and  BCL2  [73].  Ywhab’s
encoded protein is known to interact with RAF and BRAF
[74,75],  and  CDC25A/B  [65,76].  It  is  possible  that  the
involvement of Ywhab and Ywhaz in the Gap43/Pten network
may be to preserve the retinal ganglion cell homeostasis since
retinal ganglion cells are one of the most metabolically active/
energy  demanding  cell  types  and  they  depend  upon  the
increased activity of prosurvival genes to sustain their normal
function [77,78].
The future of this approach will extend to defining the
cell intrinsic pathways that are responsible for susceptibility
of retinal ganglion cell death and identifying networks that
underlie  the  response  of  retinal  injury.  Additionally,  this
approach will help pinpoint the complex genetic networks that
regulate inherited retinal diseases such as age related macular
degeneration,  glaucoma,  and  diabetic  retinopathy.  We
anticipate that the interactive HEI Retinal Database and the
databases listed in Table 6 will help to alleviate the major
challenges  in  identifying  and  validating  the  genes  that
contribute to retinal disease phenotypes as well as the genetic
and regulatory mechanisms that underlie the complex trait
diseases of the retina.
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1371Appendix 1.
HEI Retina case IDs, including sample tube ID, strain,
age, sex, and source of mice. To access the data, click or select
the words “Appendix 1.” This will initiate the download of a
compressed (pdf) archive that contains the file. Hamilton Eye
Institute Retina Database case IDs, including sample tube ID,
strain, age, sex, and source of mice.
Appendix 2.
Top 100 gene correlates of growth associated protein 43
(Gap43).  To  access  the  data,  click  or  select  the  words
“Appendix 2.” This will initiate the download of a compressed
(pdf) archive that contains the file.
Appendix 3.
The genes shared in the top 2,000 correlates of growth
associated  protein  43  (Gap43)  and  phosphatase  tensin
homolog (Pten). To access the data, click or select the words
“Appendix 3.” This will initiate the download of a compressed
(pdf) archive that contains the file.
Appendix 4.
List of genes that share genetic correlations among the
growth associated protein 43/ phosphatase tensin homolog
(Gap43/Pten) network within the retina. To access the data,
click or select the words “Appendix 4.” This will initiate the
download of a compressed (pdf) archive that contains the file.
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